Phosphorus Or Phosphorus Compound Patents (Class 424/601)
-
Patent number: 6440390Abstract: A formulation for use in the controlled generation of phosphine comprises a mixture of a particulate phosphide and a water-immiscible compound. The water-immiscible compound is paraffin oil, petroleum jelly, a mixture of these materials or a wax having a melting point in the range 35° C. to 65° C. The phosphide comprises from 65 to 85 per cent (by weight) of the formulation. Such a formulation can be added progressively to water in a reaction chamber. Alternatively, the formulation can be packaged in a water-impermeable container from which a region can be removed to expose the formulation to water vapor in a gas flowing past the container. The water or the water vapor reacts with the phosphide particles as they become exposed to form phosphine. The phosphine, mixed with a carrier (usually air), may be fed into a duct connected to a grain silo, for fumigation of grain stored in the silo.Type: GrantFiled: May 18, 1999Date of Patent: August 27, 2002Assignee: Commonwealth Scientific and Industrial Research OrganisationInventors: Colin Joseph Waterford, Robert Gordon Winks
-
Patent number: 6436444Abstract: The mastitis control teat dip composition of the invention provides rapid initial kill, a useful highly pseudoplastic rheology, a barrier/film-forming capacity, a unique antimicrobial composition that is stable over an extended period of time, and unexpected long term microbial control when compared to the prior art materials disclosed in patents and used in the marketplace. The compositions of the invention are made by combining an aqueous thickened liquid composition containing the organic components which can be combined with a simple aqueous solution of a salt of chlorous acid, preferably an alkali metal chlorite. The materials can be combined, blended into a smooth viscous material and can be immediately contacted with the target animals. The .compositions of the invention provide rapid initial kill, consistent long term kill and chemical and rheological stability.Type: GrantFiled: September 26, 1997Date of Patent: August 20, 2002Assignee: Ecolab Inc.Inventors: Francis L. Richter, Cathy M. Paquette, Richard K. Staub
-
Publication number: 20020102313Abstract: A composition for the relief of heat stress, particularly for restoration of electrolyte balance due to passive exposure to heat resulting in excessive transpiration/perspiration, without strenuous physical activity, comprises predetermined levels of selected electrolytes including, in part by weight, sodium ion not exceeding 250 parts, at least 100 parts of potassium ion, at least 100 parts of magnesium ion, and carbohydrates not exceeding 2.5% by weight, as needed for organoleptic purposes only. The composition can further include up to 30 parts of zinc, up to 10 parts of manganese, and from 65 to 400 parts of calcium. Furthermore, the composition can comprise oligoelements, dermoprotective vitamins and anti-oxidants so as to compensate for the chemical changes which might occur in the skin of a person passively exposed to heat.Type: ApplicationFiled: February 13, 2002Publication date: August 1, 2002Applicant: ALL SUN HSF COMPANY LIMITEDInventors: Fausto Armonti, Donato Mitola, Jacobus C. Samson
-
Publication number: 20020098210Abstract: Compositions and methods are provided for inhibiting skin irritation attributable to chemical irritants, including skin exfoliant irritants, and environmental conditions by the application of an anti-irritant amount of aqueous-soluble divalent calcium cation.Type: ApplicationFiled: September 21, 1999Publication date: July 25, 2002Inventors: GARY S. HAHN, David O. Thueson
-
Patent number: 6423343Abstract: This invention relates to a method for treating inflammatory symptoms such as burning, redness, itching, swelling and pain which accompany skin disorders other than wounds of the skin. The method comprising topical application of a topical medicinal composition comprising a non-interlinked, particulate bioactive glass mixed with a topical medicinal carrier to the site of the skin disorder.Type: GrantFiled: January 23, 1998Date of Patent: July 23, 2002Assignee: USBiomaterials CorporationInventors: Sean Lee, James L. Meyers
-
Patent number: 6423348Abstract: What is shown is an animal blood anticoagulant compound useful in the meat packing industry generally, and in slaughterhouse operations, particularly. The anticoagulant is effective when diluted with water at higher dilution ratios than earlier anticoagulants. In some field trials, this anticoagulant was at least as effective as previously known commercial anticoagulants when diluted by an additional 30%. The present anticoagulant preparation concentrate is an aqueous mixture of soft water (55.0%-65.0/%, w/w); tetrasodium ethylene diamine tetraacetate (Na4EDTA) (0.5%-3.0%, w/w); sodium hexametaphosphate (17.0%-24.0%, w/w); citric acid (5.0%-9.0%, w/w); and sodium hydroxide (4.0%-7.0%, w/w) to obtain a balanced pH that provides optimal chelating and anticoagulant activity. Optimal anticoagulant performance has been found to occur in the range of between pH 6.6 and pH 7.2.Type: GrantFiled: December 15, 1998Date of Patent: July 23, 2002Inventor: James C. Mickus
-
Patent number: 6387414Abstract: A method for preparing a hydroxyapatite composite is disclosed. This method comprises alternately soaking a matrix which has been made hydrophilic at least on its surface, in a calcium ion aqueous solution containing calcium ions and substantially free of phosphate ions and in a phosphate ion aqueous solution containing phosphate ions and substantially free of calcium ions to securely form hydroxyapatite at least on the surface of the matrix. Also disclosed is a biocompatible material composed of the hydroxyapatite composite obtained by the method.Type: GrantFiled: August 5, 1999Date of Patent: May 14, 2002Assignees: NOF CorporationInventors: Mitsuru Akashi, Tetsushi Taguchi, Akio Kishida, Akio Hayashi
-
Patent number: 6379711Abstract: Phosphomolybdic acid and partial alkali salts of phosphomolybdic acid are used as stabilizers for aqueous hydrogen peroxide.Type: GrantFiled: January 27, 2000Date of Patent: April 30, 2002Assignee: Crompton CorporationInventors: Peter Frenkel, Ted M. Pettijohn
-
Publication number: 20020048609Abstract: A fungicidal composition for plants containing phosphonate (PO3) and phosphate (PO4) salts, and derivatives thereof is disclosed. The composition provides a single product which may be employed to control a Phytophthora infestans infection in plants.Type: ApplicationFiled: September 18, 2001Publication date: April 25, 2002Inventor: John B. Taylor
-
Patent number: 6372238Abstract: A process for providing nutrient material for banana and plantain plants, comprising providing a slow release implant containing a banana and plantain nutrient material and implanting the implant into banana or plantain plants whereby the nutrient is slowly released into the plant over a period of time.Type: GrantFiled: March 17, 2000Date of Patent: April 16, 2002Inventor: Ambrose H. J. Rajamannan
-
Patent number: 6358938Abstract: Synergistic fungicidal composition comprising propamocarb and a derivative of phosphorous acid; and process for the curative or preventative control of phytopathogenic fungi by use of such a composition.Type: GrantFiled: February 15, 2000Date of Patent: March 19, 2002Assignee: Rhone-Poulenc AgroInventors: Joƫlle Donnadieu, Patrice Duvert, Richard Mercer
-
Patent number: 6355277Abstract: There is disclosed a method of improving the smoke suppressant characteristics of halogen-containing polymeric compositions which comprises adding to said polymeric compositions a smoke retardant amount of (1) a complex of a cuprous halide and a phosphite, and (2) an amine molybdate which contains no residual molybdenum trioxide prepared by reacting an amine with molybdenum trioxide in an aqueous acidic medium under greater than atmospheric pressure and at a temperature of from 105-150° C.Type: GrantFiled: July 14, 2000Date of Patent: March 12, 2002Assignee: Unitex Chemical CorporationInventors: James F. Day, Chad E. Lee
-
Patent number: 6350474Abstract: The invention deals with phosphate water solution with cold solidification capacity. Phosphate composition containing iron oxide solution in acid, water, advantages from the following properties; it contains orthophosphorus acid and in addition metal powder. Phosphate composition is ecologically pure product, non toxic, non cancerogenic, non-allergic. It has antimicrobial, antivirus and fungicidal properties. Phosphate composition can be applied within medicine: surgery, dermatology, dentistry, oncology, pharmacology and other branches. In agriculture use: as a means of curing plant diseases, within veterinary—as a means for preventive maintenance and curing of animal diseases, within construction—as an anticorrosive, fire-resistant, hydro-electric isolating covers, ceramic tiles, concretes, which protect against radiation, as well as for producing other composite materials.Type: GrantFiled: June 7, 1999Date of Patent: February 26, 2002Inventors: David Dzneladze, Andro Dzneladze, Nargisa Jabishvili
-
Publication number: 20020022058Abstract: The invention provides a unit dose of an orally consumable material, having a predetermined pharmaceutically effective amount of at least one nonprescription discomfort reliever and a predetermined nutritionally effective amount of at least one nutritional supplement. Each unit dose may be in a container having indications of the amount discomfort reliever and the amount of nutritional supplement in each unit dose. Instructions are provided for consuming the material for discomfort relief and supplementing nutrition. Consumption of the unit dose simultaneously relieves discomfort and supplements nutrition.Type: ApplicationFiled: July 7, 2001Publication date: February 21, 2002Inventor: Dale R. Lovercheck
-
Patent number: 6346279Abstract: An acidic aqueous hydrogen peroxid solution is provided, with improved disinfectant activity. Concentrated solutions preferably contain up to about 8% and as-used concentrations contain about 0.5% peroxide. The solution also contains from 0.1 to 5.0% of at least one acid compound, e.g. phosphoric and/or a phosphonate with from 1 to 5 phosphonic acid groups, and from 0.02 to 5% of at least one anionic surfactant. The surfactant is selected from C8 to C16-alkyl aryl sulphonic acids, sulphonated C12 to C22 carboxylic acids, C8 to C22-alkyl diphenyl oxide sulphonic acids, naphthalene sulphonic acids, C8 to C22 alkyl sulphonic acids, and alkali metal and ammonium salts thereof, and alkali metal C8 to C18 alkyl sulphates, and mixtures thereof. Most preferably the solution has an emulsifier, e.g. a salt of an alkylated diphenyl oxide. The solution may also contain corrosion inhibitors and/or lower alcohols.Type: GrantFiled: July 19, 1999Date of Patent: February 12, 2002Assignee: Virox Technologies, Inc.Inventor: Michael J. Rochon
-
Patent number: 6338860Abstract: A fungicidal composition for plants containing phosphonate (PO3) and phosphate (PO4) salts, and derivatives thereof is disclosed. The composition provides a single product which may be employed to control a Phytophthora infestans infection in plants.Type: GrantFiled: October 15, 1999Date of Patent: January 15, 2002Assignee: Foliar Nutrients, Inc.Inventor: John B. Taylor
-
Publication number: 20010055603Abstract: It is an object of the present invention to provide a water-soluble antibacterial polymer having an excellent antibacterial property and stability, and a liquid formulation comprising it for contact lenses, which is suitably used for disinfection or preservation of contact lenses.Type: ApplicationFiled: November 12, 1998Publication date: December 27, 2001Inventors: KAZUHIKO NAKADA, SADANORI OONO
-
Patent number: 6333193Abstract: Provided are a cell growth accelerator containing a polyphosphoric acid and a cell growth method in which cells are grown by adding the cell growth accelerator to a medium for cells of animals and plants or by using a glass or plastic cell cultivator containing or coated with the cell growth accelerator. When substances are produced in vitro using culture cells, the cell culture and the cell growth acceleration are conducted at low cost safely and efficiently by adding the cell growth accelerator containing the polyphosphoric acid to the medium for cells of animals and plants or by using the cell cultivator containing or coated with the cell growth accelerator.Type: GrantFiled: August 27, 1999Date of Patent: December 25, 2001Assignee: Nipro CorporationInventor: Toshikazu Shiba
-
Publication number: 20010051189Abstract: Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms for the administration of active macromolecules. The nanoparticles (having a nanometric size and a hydrophilic character), also called nanospheres or latex, are colloidal systems comprised of the combination of hydrophilic polymers and an active ingredient having a high molecular weight (active macromolecule, molecular weight higher than 1000 daltons). The hydrophilic polymers are the chitosan (an aminopolysaccharide) or its derivatives and polyoxyethylene or its derivatives. The association of the active macromolecule to said nanoparticles takes place in an aqueous phase without having to use organic solvents or auxiliary toxic substances. The active ingredient charge capacity of the nanoparticles is extremely high and additionally said charge is released in a controlled and time extended way. Additionally, said nanoparticles have a positive surface electric charge whose intensity may vary in relation to its composition.Type: ApplicationFiled: July 18, 2001Publication date: December 13, 2001Applicant: Universidade de Santiago de CompostelaInventors: Maria J. Alonso Fernandez, Pilar Calvo Salve, Carmen Remunan Lopez, Jose L. Vila Jato
-
Publication number: 20010043951Abstract: Disclosed is a polyphosphate for use in promoting wound healing and scar abatement, represented by the following chemical formula 1. The polyphosphate can effectively promote the healing of wounds resulting from surgical operation or cutting without leaving scars, thereby encouraging patients to overcome loss of self-esteem. In addition, the medicinal aid can heal wounds effectively and economically while lessening scars.Type: ApplicationFiled: March 26, 2001Publication date: November 22, 2001Applicant: KYUNG WON MEDICAL CO., LTD.Inventors: Hong Yeoul Kim, Ho Yeon Lee
-
Publication number: 20010041191Abstract: A method of treating solid neoplastic diseases is disclosed, which involves administering to a host in need of such treatment an effective amount of a pharmaceutically acceptable magnesium salt or complex, which can be a pharmaceutically acceptable inorganic magnesium salt such as magnesium pyrophosphate, or a pharmaceutically acceptable organic magnesium salt. The composition can be administered orally, parenterally, cutaneously or mucosally, and can be given, for example, in an amount of magnesium which is from 2 to 12 mg per kg of body weight daily. Preferred compositions include magnesium lactate, magnesium aspartate, magnesium acetate, and magnesium pyrophosphate. Neoplastic diseases amenable to the method include adenocarcinoma. The method can include administering with the magnesium salt or complex an effective amount of a pharmaceutically acceptable magnesium fixing substance, such as vitamin B6.Type: ApplicationFiled: May 11, 2001Publication date: November 15, 2001Inventor: Giampiero Valletta
-
Patent number: 6312662Abstract: Prodrugs of formula I, their uses, their intermediates, and their method of manufacture are described:Type: GrantFiled: September 8, 1999Date of Patent: November 6, 2001Assignee: Metabasis Therapeutics, Inc.Inventors: Mark D. Erion, K. Raja Reddy, Edward D. Robinson, Bheemarao G. Ugarkar
-
Patent number: 6305384Abstract: In a system for coating human skin, a chemical composition, such as a cosmetic or medical formulation, is uniformly coated over the entire body or selected parts of the body of the person being coated. The system includes atomization of the coating composition, containment of the atomized spray, and residual recovery which together yield a novel method for applying chemical compositions.Type: GrantFiled: December 29, 2000Date of Patent: October 23, 2001Assignee: Laughlin Products, Inc.Inventor: Thomas J. Laughlin
-
Patent number: 6303155Abstract: A method for restoration of the circadian rhythm of parathyroid hormone (PTH) serum levels in a subject having osteoporosis, so as to restore a circadian rhythm of PTH levels which is similar to that existing in normal subjects is disclosed by administering a single daily dose of a composition consisting essentially of an effective amount of phosphate in the evening or at night, whereby the composition causes a circadian rhythm of PTH levels which peaks during the night, whereby the circadian rhythm of PTH levels is restored to that which is similar to that existing in normal subjects, thereby treating osteoporosis.Type: GrantFiled: March 1, 1999Date of Patent: October 16, 2001Assignee: Hadasit Medical Research Services and Development Company, Ltd.Inventor: Justin Silver
-
Patent number: 6294006Abstract: An anticorrosive and antifouling additive for paints, which is effective to protect structures such as steel ships and pipes from rust, and prevent the adhesion of marine organisms and algae to the structures used in seawater without adversely affecting the marine environment, and a paint containing the same additive are provided. The additive comprises 70 to 94% by weight of at least one selected from the group consisting of bastnasite, monazite and Chinese complex mineral, 3% by weight or more of tourmaline, and 3% by weight or more of zircon, with respect to the total amount of the additive. The additive emits a required amount of negative ions to achieve the effect of preventing the adhesion of marine organisms and algae and prevents the occurrence of rust. In practical use, the additive can be added to a conventional paint in an amount of 8 to 15% with respect to paint weight.Type: GrantFiled: October 11, 2000Date of Patent: September 25, 2001Assignee: Nazca Co., Ltd.Inventor: Hiroshi Andou
-
Patent number: 6287551Abstract: A solution or gel composition containing activated chlorine dioxide and phosphates, such as disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, and sodium monofluorophosphate, is disclosed for treating herpes virus. The preferred concentration ranges are between about 0.005% to about 2.0% chlorine dioxide, and between about 0.02% to about 3.0% of a phosphate compound. The phosphate compound retards escape of chlorine dioxide in the pH range of 6.0 to 7.4, at which pH chlorine dioxide becomes activated and releases sufficient chlorine dioxide to reduce motility and become lethal to the involved micro-organisms.Type: GrantFiled: November 3, 2000Date of Patent: September 11, 2001Assignee: Vortech, Inc.Inventor: Perry A. Ratcliff
-
Patent number: 6284502Abstract: A process is provided for converting phytate in a food into inorganic phosphate. The process comprises the steps of: (i) mechanically mixing a slurry comprising: (a) 100 parts by weight of the phytate-containing food, (b) 60-1000 parts by weight of a solvent mixture which comprises water and a water-immiscible organic solvent having a boiling point of 20-100° C., the water-immiscible organic solvent constituting 20-85% by wt. of the solvent mixture, and (c) a phytase; and (ii) drying the food to remove the organic solvent. The process has the advantage of enabling a high conversion rate of phytate into inorganic phosphate in an economical manner.Type: GrantFiled: August 19, 1999Date of Patent: September 4, 2001Assignee: University of SaskatchewanInventors: David Daniel Maenz, Henry Leonard Classen, Rex Wayne Newkirk
-
Patent number: 6280715Abstract: Cosmetic composition useful notably in the whitening of skin which it includes, in association with any suitable excipient, at least one compound of the following general formula (I): wherein: R1 represents a hydrogen atom, a linear or branched alkyl group or a thiazoline group, R2 represents a hydrogen atom, a linear or branched alkyl group or a linear or branched alkyl group substituted by a carboxyl, a hydroxyl, an amine or a thiol group, R3 represents a hydrogen atom, a linear or branched alkyl group, an arylalkyl group, an acyl group or an acyloxy group, R4 represents a hydrogen atom or a linear or branched alkyl group, R5 represents a hydrogen atom, a hydroxyl group or a linear or branched alkyl group.Type: GrantFiled: July 31, 1998Date of Patent: August 28, 2001Assignees: Exsymol S.A.M.Inventors: Marie-Christine Seguin, Mark A. Babizhayev
-
Patent number: 6277829Abstract: The present invention describes a process for the preparation of aqueous formulations containing azithromycin for ophthalmic use, as well any formulations obtained by this process and their topical use in the ocular bacterial infections, more preferably in the treatment of conjunctivitis, keratitis and blepharitis.Type: GrantFiled: December 27, 1999Date of Patent: August 21, 2001Assignee: S.I.F.I. Societa Industria Farmaceutica Italiana S.p.A.Inventors: Antonino Asero, Maria Grazia Mazzone, Valeria Moschetti, Anna Rita Blanco
-
Patent number: 6277414Abstract: The present invention relates to an aqueous decontaminating composition comprising (A) an amount of H2O2 less than or equal to 60% by weight, based on the total weight of said composition; (B) an RCO3H/RCO2H mixture, where R is methyl or ethyl, as indicated above, said mixture being present in an amount such that the weight ratio of said mixture to the hydrogen peroxide is between 0.15/1 and 0.85/1; (C) a silver component as a source of Ag ions, selected from the group consisting of silver salts and complexes, said silver component being present in an amount such that the weight ratio of said silver component to the hydrogen peroxide is between 0.0005/1 and 0.015/1; (D) a stabilizer present in an amount such that the weight ratio of said stabilizer to the hydrogen peroxide is between 0.0005/1 and 0.025/1; and water to make up to 100% by weight. It further relates to the method of preparation and to the use of said composition.Type: GrantFiled: September 22, 1998Date of Patent: August 21, 2001Assignee: SodifraInventors: Alain Elhaik, Raphaƫl Alex De Nicola
-
Patent number: 6277363Abstract: A solution or gel composition containing activated chlorine dioxide and a phosphate compound, such as disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, and sodium monofluorophosphate, is disclosed for treating a Chlamydia infection. The preferred concentration ranges are between about 0.005% to about 2.0% chlorine dioxide, and between about 0.02% to about 3.0% phosphate compound. The phosphate compound retards escape of chlorine dioxide in the pH range of 6.0 to 7.4, at which pH the chlorine dioxide becomes activated and releases sufficient chlorine dioxide to reduce motility and become lethal to the involved micro-organisms.Type: GrantFiled: November 3, 2000Date of Patent: August 21, 2001Assignee: Vortech, Inc.Inventor: Perry A. Ratcliff
-
Patent number: 6274121Abstract: Superparamagnetic particles consist of superparamagnetic one-domain particles and aggregates of superparamagnetic one-domain particles to whose surfaces are bound inorganic and optionally organic substances optionally having further binding sites for coupling to tissue-specific binding substances, diagnostic or pharmacologically active substances. The superparamagnetic particles consist of a mixture of small superparamagnetic one-domain particles with a particle size from 3 to 50 nm and stable, degradable aggregates of small superparamagnetic one-domain particles with a particle size from 10 to 1000 nm. They are made of iron hydroxyide, iron oxide hydrate, iron oxides, iron mixed oxides or iron to the surface of which are bound silicate group containing substances among the orthosilicic acids and their condensation products and phosphate-group containing substances among the ortho- or metaphosphoric acids and their condensation products. These substances may have further binding sites.Type: GrantFiled: April 27, 1999Date of Patent: August 14, 2001Inventor: Herbert Pilgrimm
-
Patent number: 6274132Abstract: A method and solution or gel composition containing activated chlorine dioxide and phosphates, such as disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, and sodium monofluorophosphate, is disclosed for lubricating the vagina and for treating HIV. The preferred concentration ranges are between about 0.005% to about 2.0% chlorine dioxide, and between about 0.02% to about 3.0% phosphate. The phosphate compound retards escape of chlorine dioxide in the pH range of about 6.0 to 7.4, at which pH the chlorine dioxide becomes activated and releases sufficient chlorine dioxide to reduce motility and become lethal to the involved micro-organisms.Type: GrantFiled: November 3, 2000Date of Patent: August 14, 2001Assignee: Vortech, Inc.Inventor: Perry A. Ratcliff
-
Patent number: 6264993Abstract: The present invention relates to fungicidal compositions and their use as a method for controlling phytopathogenic fungi comprising the application of a selected fungicidally active N-acetonylbenzamide compound and a second fungicidally active compound selected from the group consisting of an inhibitor of respiration at cytochrome complex III, ziram, fluazinam, zarilamide, chlorothalonil, propamocarb, folpet, fosetyl-aluminum or a fungitoxic metabolite thereof, phosphorous acid or a salt thereof, a triphenyltin type fungicide and a copper containing fungicide to plant seed, to plant foliage or to a plant growth medium. The compositions and method of use provide higher fungicidal activity than separate use of the same compounds.Type: GrantFiled: April 28, 2000Date of Patent: July 24, 2001Assignee: Rohm and Haas CompanyInventors: David Hamilton Young, Willie Joe Wilson, Anne Ritchie Egan, Enrique Luis Michelott
-
Patent number: 6261591Abstract: Nutritionally balanced dog food compositions containing a dietary source of pyrophosphate, for reducing the incidence and extent of hip joint subluxation in dogs, and method of use. One embodiment of the dog food composition includes about 2.0% by weight sodium acid pyrophosphate. In use and in one embodiment of the method a puppy is fed the dog food composition as substantially the sole diet from weaning at about 6-8 weeks of age to about 2 years of age, to improve hip joint stability and reduce the incidence and severity of canine hip dysplasia.Type: GrantFiled: February 9, 1999Date of Patent: July 17, 2001Assignee: Ralston Purina CompanyInventor: Richard D. Kealy
-
Patent number: 6254879Abstract: The invention concerns a new pharmaceutical agent for oral or topical administration in the treatment of protozoal diseases, in particular of leishmaniasis, which contains as the active substance one or several compounds having the general formula I in which R1 is a saturated or monounsaturated or polyunsaturated hydrocarbon residue with 12 to 20 C atoms and R2, R3 and R4 denote independently of one another hydrogen, a C1-C5 alkyl group, a C3-C6 cycloalkyl group or a C1-C5 hydroxyalkyl group whereby two of the residues R2, R3 and R4 can together form a C2-C5 alkylene group which, if desired, can be substituted with an —O—, —S— or NR5 group, in which R5 is hydrogen, a C1-C5 alkyl group, a C3-C6 cycloalkyl group or a C1-C5 hydroxyalkyl group as well as, if desired the usual pharmaceutical auxiliary, diluting, carrier or/and filling substances.Type: GrantFiled: July 23, 1999Date of Patent: July 3, 2001Assignees: Max-Planck-Gessellschaft zun Fƶrderung der Wissenschaften e.V., Asta Medica AGInventors: Hansjƶrg Eibl, Clemens Unger, JĆ¼rgen Engel
-
Patent number: 6248368Abstract: Pharmaceutically acceptable compositions suitable for releasing magnesium ions to an organism, such as organic or inorganic magnesium salts or complexes thereof, are used to prevent and to treat neoplastic and autoimmune diseases, whose origin can be attributed to magnesium depletion. For the new therapeutic indications the magnesium based product, preferably magnesium pyrophosphate, is usually administered orally or parenterally, preferably in association with vitamin B6.Type: GrantFiled: November 21, 1996Date of Patent: June 19, 2001Inventor: Giampiero Valletta
-
Patent number: 6197815Abstract: Metal amino acid chelates for animals are beneficial for facilitating and promoting growth by increasing desired metallic ion uptake. The present invention is directed to a process for providing an animal fed additive by preparing metal amino acid chelates, and the metal amino acid chelate growth facilitator, promoter and enhancer prepared by the process.Type: GrantFiled: March 18, 1998Date of Patent: March 6, 2001Assignee: J.H. Biotech, Inc.Inventor: Hsinhung John Hsu
-
Patent number: 6159473Abstract: A novel throat spray composition is provided that is useful for topical application to sore throats. The throat spray composition contains Piper methysticum (Kava Kava) as its main active ingredient, and is a suitable alternative to phenol-based over-the-counter throat sprays. Piper methysticum is used for its little known or utilized analgesic property, which provides a soothing and numbing effect to the throat. Additional ingredients include Echinacea angustifolia, Eucalyptus globulus, Thymus vulgaris, Lycopodium clavatum, Phytolacca decandra, Capsicum annum, Mentha piperita, and Phosphorus, which, together with Piper methysticum, offer temporary relief of sore throat pain, irritation, difficulty swallowing, and symptoms of hoarseness or laryngitis.Type: GrantFiled: June 24, 1998Date of Patent: December 12, 2000Assignee: Botanical Laboratories, Inc.Inventors: Mary Beth Watkins, James H. Coyne
-
Patent number: 6159505Abstract: Compositions for the treatment and prevention of migraine or stress headaches wherein there is supplied a combination of potassium, magnesium and pyridoxine optionally in association with other nutrients and/or simple analgesics.Type: GrantFiled: January 21, 1998Date of Patent: December 12, 2000Inventor: Edwina M. Piper
-
Patent number: 6156740Abstract: Synergistic fungicidal composition comprising a compound analogous to strobilurin of formula (I): ##STR1## in which: A is the nitrogen atom or the --CH group,B is the --OCH.sub.2 -- or --CH.sub.2 O-- or CH(CH.sub.3)--O--N.dbd.CH-- or --CH.dbd.N--O--CH(CH.sub.3)-- group or the group ##STR2## R.sub.1 is an alkyl group containing 1 to 4 carbon atoms, R.sub.2 is --OCH.sub.3 or --NHCH.sub.3,X is a halogen atom, the cyano group or an alkyl or haloalkyl group containing 1 to 4 carbon atoms,n is equal to 1 or 2, with, when n is equal to 2, the possibility of having different X groups,and at least one fungicidal compound B, anda process for the curative or preventive control of phytopathogenic fungi using the composition.Type: GrantFiled: December 1, 1999Date of Patent: December 5, 2000Assignee: Rhone-Poulenc AgrochimieInventor: Patrice Duvert
-
Patent number: 6143881Abstract: The invention provides hybrid oligonucleotides having phosphorothioate or phosphorodithioate internucleotide linkages, and both deoxyribonucleosides and ribonucleosides or 2'-substituted ribonucleosides. Such hybrid oligonucleotides have superior properties of duplex formation with RNA, nuclease resistance, and RNase H activation.Type: GrantFiled: June 7, 1995Date of Patent: November 7, 2000Assignee: University of Massachusetts WorcesterInventors: Valeri Metelev, Sudhir Agrawal
-
Patent number: 6132776Abstract: Methods and compositions related to HIV are disclosed. Using the methods of the present invention, nucleoside analogs may be screened for the ability to be incorporated by reverse transcriptase of human immunodeficiency virus ("HIV RT") and cause incorrect base pairing. Progressive mutation of the virus by such nucleoside analogs renders it non-viable.Type: GrantFiled: June 16, 1997Date of Patent: October 17, 2000Assignee: University of WashingtonInventors: Lawrence A. Loeb, John M. Essigmann
-
Patent number: 6123966Abstract: A stabilized two-part disinfecting system comprising a first part and a second part adapted to be mixed to yield an aqueous disinfecting composition. The first part contains a non-esterifying acid and an alcohol-containing humectant or antifreeze, while the second part contains a salt of an organic acid and an optional metal chlorite. Methods for making a disinfecting composition by mixing the two-part disinfecting system, as well as for disinfecting substrates by contact therewith, are also disclosed.Type: GrantFiled: September 3, 1998Date of Patent: September 26, 2000Assignee: Alcide CorporationInventor: Robert D. Kross
-
Patent number: 6113949Abstract: This invention relates to a weight control composition, preferably in the form of a capsule or tablet, comprising a mixture of guggul extract and at least one phosphate salt selected from calcium phosphate, potassium phosphate and sodium phosphate. The composition evidences synergistic activity in reducing body weight and percent body fat in mammals. The guggul extract/phosphate salt product also reduces plasma lipid levels and cholesterol in overweight hyperlipidaemic humans. The inventive composition may also contain at least one additional component selected from phosphatidylcholine, hydroxycitric acid and L-tyrosine.Type: GrantFiled: October 27, 1998Date of Patent: September 5, 2000Assignee: Prolab Nutrition, Inc.Inventor: William DesIsles Brink
-
Patent number: 6068860Abstract: The invention relates to a pharmaceutical composition for topical administration comprising a combination of foscarnet and an antiinflammatory glucocorticoid, in admixture with a carrier based on galactolipids and a polar solvent. The pharmaceutical composition can be used in a prophylactic and/or curative treatment of herpesvirus infections in mammals including man.The invention also relates to the use of said pharmaceutical composition in the manufacture of a medicament for said prophylactic or curative treatment.Type: GrantFiled: March 8, 1996Date of Patent: May 30, 2000Assignee: Astra AktiebolagInventors: Anders Nils-Erik Carlsson, Johan Georg Harmenberg, Bengt Goran Herslof, Ann Harriet Margareta Kristofferson, Stefan Karl Lundquist
-
Patent number: 6063406Abstract: The present invention includes a process and composition for treating skin disorders. The composition of the present invention comprises 94.0 to 99.2 percent by weight of cation-free water, 0.1 to 1.0 percent by weight of Calcium chloride, 0.0 to 2.0 percent by weight of linear long chain polyphosphate, 0.1 to 1.0 percent by weight of sodium bicarbonate and 0.5 to 3.0 percent by weight of cross-linked polyacrylamide polymer.Type: GrantFiled: April 17, 1998Date of Patent: May 16, 2000Assignee: Chemcraft, Inc.Inventor: Richard S. Hornack
-
Patent number: 6051236Abstract: A nutritional composition in a dry powder form for optimizing muscle performance during exercise and for enhancing muscle cell repair and recovery following the cessation of exercise. The dry nutritional composition includes carbohydrates and proteins in a ratio in the range of 2.8 to 4.2 parts of the carbohydrates to 1.0 part of the proteins, wherein the carbohydrates are used for providing energy during exercise and the proteins are used for stimulating the release of insulin to the muscle cells during exercise and for repairing muscle cells after exercise.Type: GrantFiled: November 12, 1998Date of Patent: April 18, 2000Assignee: Pacifichealth Laboratories, Inc.Inventor: Robert Portman
-
Patent number: 6039943Abstract: A thimerosal-free hyaluronidase is prepared wherein the preferred hyaluronidase is devoid of molecular weight fractions below 40,000 MW, between 60-70,000 MW and above 100,000 MW. Also a method for accelerating the clearance of hemorrhagic blood from the vitreous humor of the eye is carried out by contacting at least one hemorrhage-clearing enzyme (e.g., hyaluronidase, .beta.-glucuronidase, matrix metalloproteinase, chondroitinase, chondroitin sulfatase or protein kinase) with the vitreous humor in an amount which is effective to cause accelerated clearance of blood therefrom.Type: GrantFiled: August 24, 1998Date of Patent: March 21, 2000Assignee: Advanced Corneal SystemsInventors: Hampar L. Karageozian, Vicken H. Karageozian, Maria Cristina Kenney, Jose Luis Gutierrez Flores, Gabriel Arturo Carpio Aragon, Anthony B. Nesburn
-
Patent number: 6039981Abstract: An antifungal oral composition comprising a fused mixture of itraconazole and phosphoric acid provides a high in vivo bioavailability of itraconazole.Type: GrantFiled: October 4, 1999Date of Patent: March 21, 2000Assignee: Hanmi Pharm. Co. Ltd.Inventors: Jong-Soo Woo, Hong-Gi Yi